Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

about

Waldenstrom's Macroglobulinemia: An Update.

P2860

Q47736653-E5F448CC-BC5E-43D2-AF6E-E0192FA90489

P2860

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

Item

http://www.wikidata.org/entity/Q48172125

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@en

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@nl

type

Item

label

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@en

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@nl

prefLabel

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@en

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@nl

P1476

Serum IgM level as predictor o ...... aldenström macroglobulinaemia.

@en

P2093

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

Joshua N Gustine

http://www.w3.org/2001/XMLSchema#string

Kirsten Meid

http://www.w3.org/2001/XMLSchema#string

Lian Xu

http://www.w3.org/2001/XMLSchema#string

Steven P Treon

http://www.w3.org/2001/XMLSchema#string

Toni Dubeau

http://www.w3.org/2001/XMLSchema#string

P2860

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

How I treat Waldenström macroglobulinemia

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

Hyperviscosity-related retinopathy in waldenstrom macroglobulinemia.

Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.

Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.

Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.

IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia.

P304

717-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14743

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Castillo

Zachary Hunter

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485115

http://www.w3.org/2001/XMLSchema#string

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

about

P2860

P2860

Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinaemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698